Market Cap

Gilead Sciences, Inc. Market Capitalization:

$82.96 Billion

USD as of July 1, 2024

business Gilead Sciences, Inc. Company Profile

Gilead Sciences, Inc. Main Stock Listing

NASDAQ: GILD

Market Capitalization History of Gilead Sciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Gilead Sciences, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $105.27 B -2.24%
Jan. 1, 2023 $107.68 B 25.07%
Jan. 1, 2022 $86.09 B 4.70%
Jan. 1, 2021 $82.23 B 3.80%
Jan. 1, 2020 $79.22 B -9.73%
Jan. 1, 2019 $87.76 B -16.46%
Jan. 1, 2018 $105.04 B 15.67%
Jan. 1, 2017 $90.82 B -12.71%
Jan. 1, 2016 $104.04 B -20.82%
Jan. 1, 2015 $131.41 B 29.98%
Jan. 1, 2014 $101.10 B 104.44%
Jan. 1, 2013 $49.45 B 61.48%
Jan. 1, 2012 $30.62 B 27.31%
Jan. 1, 2011 $24.05 B -20.49%
Jan. 1, 2010 $30.25 B -4.92%
Jan. 1, 2009 $31.82 B 11.12%
Jan. 1, 2008 $28.64 B 42.07%
Jan. 1, 2007 $20.16 B 5.67%
Jan. 1, 2006 $19.08 B 83.90%
Jan. 1, 2005 $10.37 B 20.78%
Jan. 1, 2004 $8.59 B 57.05%
Jan. 1, 2003 $5.47 B 6.70%
Jan. 1, 2002 $5.13 B 93.30%
Jan. 1, 2001 $2.65 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Gilead Sciences, Inc., is a pharmaceutical and biotechnology company focusing on antiviral drugs to treat HIV, hepatitis B, hepatitis C, and influenza, notably producing and commercializing the blockbuster drugs Harvoni and Sovald. Besides, Gilead conducts research to develop a pipeline of new drugs and treatments and it also considers the acquisition of other blockbuster drugs.

business Gilead Sciences, Inc. Company Profile

Gilead Sciences, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—General
United States Healthcare United States Drug Manufacturers—General

Stocks & Indices

Gilead Sciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: GILD

Stock: BCBA: GILD

Stock: BMV: GILD

Stock: Bovespa: GILD34

Stock: FSX: GIS

Stock: MTA: GILD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.